February 2014

Findings from the International Breast Cancer Intervention Study II (IBIS II) examining the efficacy of the aromatase inhibitor anastrozole as a breast cancer preventive show that the oral agent provided significant benefit to postmenopausal women deemed at high risk

A subgroup of older breast cancer patients may be able to forgo radiation therapy (RT) after breast-conserving surgery if they are treated with hormonal therapy and considered to be at low risk for breast cancer recurrence

A new study reported at the 2013 San Antonio Breast Cancer Symposium shows that a prescribed exercise program reduces joint pain in breast cancer survivors taking aromatase inhibitors (AIs), with pain reductions observed at all levels of exercise.

Several trials of ibrutinib, an oral kinase inhibitor, either alone or in combination with currently used therapies for patients with chronic lymphocytic leukemia were presented at the 2013 ASH annual meeting.

A higher cumulative dose of the proteasome inhibitor bortezomib, including a longer duration of treatment and/or higher dose intensity, appears to improve overall survival in patients with previously untreated multiple myeloma

The electrolyte disorder hyponatremia is a common and dangerous problem among cancer patients, and vaptans designed to help bring body fluid and sodium back into balance can be useful for some patients

In the current digital age, where all-too-personal information flows from Facebook and Twitter, it seems that the health information available through the process of genetic testing would be an idea welcomed by most of the public.

When a patient is diagnosed with cancer, clinicians are understandably focused on moving forward with treatment and managing any associated adverse events.

According to the Centers for Disease Control and Prevention, 79 million Americans, most in their late teens and early 20s, are infected with the human papillomavirus. Each year, about 14 million people become newly infected.

As more cancer therapies move out of the infusion room and into the patient's home, ensuring that patients take these medications as prescribed poses an ongoing, multifaceted challenge for today's oncology practitioner.

Laurel Northouse's interest in supporting the family caregivers of patients with cancer began nearly four decades ago when the young BSN graduate became a caregiver herself at the age of 27, following her husband's diagnosis of Stage IV Hodgkin's Disease

Among the podium sessions featured at the ONS Connections conference was a panel focused on how technologies are being deployed to improve patient care.